-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tj68JbQS8StMkCjuPpnzvQPiMqCCqYPGmP5Mccoqoz+IP582ctsFdPtf1aUtx9Fe VNkoVDl9scxFPxTfeRTnPQ== 0001158833-03-000035.txt : 20030814 0001158833-03-000035.hdr.sgml : 20030814 20030814125615 ACCESSION NUMBER: 0001158833-03-000035 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030814 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIFE SCIENCES RESEARCH INC CENTRAL INDEX KEY: 0001158833 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 522340150 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-62457 FILM NUMBER: 03845231 BUSINESS ADDRESS: STREET 1: PMB #251, 211 EAST LOMBARD STREET CITY: BALTIMORE STATE: MD ZIP: 21202-6102 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAKER ANDREW H CENTRAL INDEX KEY: 0001037414 STATE OF INCORPORATION: MD FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: METTLERS ROAD STREET 2: P. O. BOX 2360 CITY: EAST MILLSTONE STATE: NJ ZIP: 08875 BUSINESS PHONE: 732-873-2550 MAIL ADDRESS: STREET 1: METTLERS ROAD STREET 2: P. O. BOX 2360 CITY: EAST MILLSTONE STATE: NJ ZIP: 08875 SC 13D/A 1 sched13da2.txt AMENDMENT NO. 2 TO SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No.2 )(1) Life Sciences Research, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Voting Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 5321691090 - -------------------------------------------------------------------------------- (CUSIP Number) Andrew H. Baker Life Sciences Research, Inc. P. O. Box 2360 Mettlers Road East Millstone, NJ 08875 (732) 873-2550 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 13, 2003 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [_]. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. (Continued on following pages) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (SC13D-07/99) CUSIP No.5321691090 13D/A ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Andrew H. Baker ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* Not applicable. ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION United Kingdom ________________________________________________________________________________ 7 SOLE VOTING POWER 200,000 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 2,270,089 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 200,000 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 2,270,089 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,470,089 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* Not applicable [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 19.7% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* IN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No.5321691090 13D/A ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Focused Healthcare Partners, Ltd. ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* Not applicable. ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Bahamas ________________________________________________________________________________ 7 SOLE VOTING POWER 0 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 684,000 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 684,000 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 684,000 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* Not applicable [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.4% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* CO ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No.5321691090 13D/A ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Focused Healthcare Partners, LLC ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* Not applicable. ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey ________________________________________________________________________________ 7 SOLE VOTING POWER 0 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 490,914 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 490,914 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 490,914 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.9% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* CO ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No.5321691090 13D/A ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) First Investments LLC ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* Not applicable. ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Nevada ________________________________________________________________________________ 7 SOLE VOTING POWER 0 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 1,095,175 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 1,095,175 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,095,175 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.7% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* CO ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 5321691090 13D/A ________________________________________________________________________________ Item 1. Security and Issuer. Class of Securities: Voting Common Stock, $.01 par value per share (the "Common Stock") Issuer: Life Sciences Research, Inc. (the "Issuer"), P.O. Box 2360, Mettlers Road, East Millstone, NJ 08875 ________________________________________________________________________________ Item 2. Identity and Background. (a) Names: Andrew H. Baker ("Baker") Focused Healthcare Partners, Ltd. ("FHP Ltd") Focused Healthcare Partners, LLC ("FHP LLC") First Investments LLC ("FI") (b) Business Address: Andrew H. Baker c/o Life Sciences Research, Inc. P.O. Box 2360, Mettlers Road East Millstone, NJ 08875 Focused Healthcare Partners, Ltd. c/o Life Sciences Research, Inc. P. O. Box 2360, Mettlers Road East Millstone, NJ 08875 Focused Healthcare Partners, LLC c/o Life Sciences Research, Inc. P. O. Box 2360, Mettlers Road East Millstone, NJ 08875 First Investments LLC 237 Tramway Drive, Box 6957 Lake Tahoe, NV 89449 (c) Principal Occupation or Employment: Baker: Chairman and CEO of the Issuer FHP Ltd Investments FHP LLC Investments FI Investments (d) Criminal Convictions: None. (e) Civil Adjudication of Violation of Securities Laws: None. (f) Citizenship: Baker: United Kingdom citizen FHP Ltd Bahamas corporation FHP LLC New Jersey limited liability company FI Nevada limited liability company ________________________________________________________________________________ Item 3. Source and Amount of Funds or Other Consideration. Not applicable. ________________________________________________________________________________ Item 4. Purpose of Transaction. (a)-(j) This filing is being made to report the withdrawal (the "Withdrawal") effective August 13, 2003, by Search for a Cure LLC ("SFC"), an entity unrelated to Baker and the owner prior to the transaction reported herein of approximately 31% of the membership interests of FI, of 240,000 shares of Common Stock from its capital account for FI. As a result of such Withdrawal, FI's beneficial ownership of shares of Common Stock was reduced from 1,335,175 to 1,095,175 and SFC's ownership of membership interests in FI was reduced from approximately 31% to approximately 16%. ________________________________________________________________________________ Item 5. Interest in Securities of the Issuer. (a) Beneficial Ownership by the Reporting Persons: Number of Shares ---------------- Baker: Aggregate number of shares: 2,470,089 Percentage: 19.7% FHP Ltd: Aggregate number of shares: 684,000 Percentage: 5.4% FHP LLC: Aggregate number of shares: 490,914 Percentage 3.9% FI: Aggregate number of shares: 1,095,175 Percentage: 8.7% All of the above percentages are calculated on the basis of 11,932,338 outstanding shares of Common Stock, plus 410,914 shares subject to a presently exercisable warrant held by FHP LLC to purchase 410,914 shares of Common Stock and 200,000 shares subject to a presently exercisable option to purchase 100,000 shares of Common Stock held by Baker, being deemed outstanding. (b) Baker: Sole Voting Power: 200,000 Shared Voting Power: 2,270,089 Sole Dispositive Power: 200,000 Shares Dispositive Power: 2,270,089 FHP Ltd: Sole Voting Power: 0 Shared Voting Power: 684,000 Sole Dispositive Power: 0 Shares Dispositive Power: 684,000 FHP LLC: Sole Voting Power: 0 Shared Voting Power: 490,914 Sole Dispositive Power: 0 Shares Dispositive Power: 490,914 FI: Sole Voting Power: 0 Shared Voting Power: 1,095,175 Sole Dispositive Power: 0 Shares Dispositive Power: 1,095,175 (c) Effective as of August 13, 2003 SFC completed the Withdrawal of 240,000 shares of Common Stock from its capital account for FI. Such Withdrawal was effected pursuant to the provisions of an operating agreement for FI (the "FI Operating Agreement"). (d) Not applicable. (e) Not applicable. ________________________________________________________________________________ Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. FHP Ltd. and FI are parties to the FI Operating Agreement. As a result of the Withdrawal, FI is the beneficial owner of 1,095,175 shares of Common Stock; FHP Ltd. owns approximately 84% of the membership interests of FI and SFC owns approximately 16% of such membership interests. By virtue of its majority ownership of FI, FHP Ltd. has voting and dispositive power over the LSR shares owned by FI. Profit distribution under the FI Operating Agreement will be made in proportion to the relative ownership interests of FHP Ltd. and SFC. ________________________________________________________________________________ Item 7. Material to be Filed as Exhibits. None. ________________________________________________________________________________ SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. August 14, 2003 ---------------------------------------- (Date) /s/ Andrew H. Baker ---------------------------------------- (Signature) Andrew H. Baker ---------------------------------------- (Name/Title) Focused Healthcare Partners, Ltd. /s/ Andrew H. Baker By: ------------------------------------ Name: Andrew H. Baker Title: President Focused Healthcare Partners LLC /s/ Andrew H. Baker By: ----------------------------------- Name: Andrew H. Baker Title: Member First Investments LLC /s/ Andrew H. Baker By: ----------------------------------- Name: Andrew H. Baker Title: Treasurer Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). EDGARLink 7.0 (8/00) Ver. 3.1 -----END PRIVACY-ENHANCED MESSAGE-----